Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianna Tortora

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Mediastinum (Hong Kong, China)|February 4, 2022
Mediastinal soft tissue sarcoma: dark sides and future lightsGiovannella Palmieri, Marianna Tortora, Sara Parola, et al.
Future Oncology (London, England)|June 30, 2018
Clinical features and psychological aspects of the decision-making process in stage I testicular germ cell tumorsCaterina Condello, Pasquale Rescigno, Margaret Ottaviano, et al.
Scientific Reports|January 8, 2026
Serum HDL subfractions are impaired by COVID-19 vaccine in patients with thymic epithelial tumorsGustavo Cernera, Pietro De Placido, Erica Pietroluongo, et al.
Infectious Agents and Cancer|May 14, 2016
Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancerMarianna Tortora, Clorinda Annunziata, Giuseppina Liguori, et al.
Clinical Chemistry and Laboratory Medicine|January 17, 2024
Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumorsGustavo Cernera, Monica Gelzo, Pietro De Placido, et al.
Mediastinum (Hong Kong, China)|March 17, 2023
The European Reference Network: the keystone for the management of rare thoracic cancersRocco Morra, Antonio D'Ambrosio, Erica Pietroluongo, et al.
Cancers|February 15, 2022
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?Liliana Montella, Margaret Ottaviano, Rocco Morra, et al.
Frontiers in Immunology|September 14, 2023
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune responseGustavo Cernera, Monica Gelzo, Pietro De Placido, et al.
AME Case Reports|November 7, 2022
The unusual first sign of presentation of renal cell carcinoma: a rare case reportRocco Morra, Antonio D'Ambrosio, Erica Pietroluongo, et al.
Biomedicines|March 29, 2023
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma ArchetypeAldo Caltavituro, Roberto Buonaiuto, Erica Pietroluongo, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Mediastinum (Hong Kong, China)|February 4, 2022
Mediastinal soft tissue sarcoma: dark sides and future lightsGiovannella Palmieri, Marianna Tortora, Sara Parola, et al.
Future Oncology (London, England)|June 30, 2018
Clinical features and psychological aspects of the decision-making process in stage I testicular germ cell tumorsCaterina Condello, Pasquale Rescigno, Margaret Ottaviano, et al.
Scientific Reports|January 8, 2026
Serum HDL subfractions are impaired by COVID-19 vaccine in patients with thymic epithelial tumorsGustavo Cernera, Pietro De Placido, Erica Pietroluongo, et al.
Infectious Agents and Cancer|May 14, 2016
Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancerMarianna Tortora, Clorinda Annunziata, Giuseppina Liguori, et al.
Clinical Chemistry and Laboratory Medicine|January 17, 2024
Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumorsGustavo Cernera, Monica Gelzo, Pietro De Placido, et al.
Mediastinum (Hong Kong, China)|March 17, 2023
The European Reference Network: the keystone for the management of rare thoracic cancersRocco Morra, Antonio D'Ambrosio, Erica Pietroluongo, et al.
Cancers|February 15, 2022
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?Liliana Montella, Margaret Ottaviano, Rocco Morra, et al.
Frontiers in Immunology|September 14, 2023
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune responseGustavo Cernera, Monica Gelzo, Pietro De Placido, et al.
AME Case Reports|November 7, 2022
The unusual first sign of presentation of renal cell carcinoma: a rare case reportRocco Morra, Antonio D'Ambrosio, Erica Pietroluongo, et al.
Biomedicines|March 29, 2023
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma ArchetypeAldo Caltavituro, Roberto Buonaiuto, Erica Pietroluongo, et al.
Pageof 3